NEW YORK ─ Salt Lake City-based Sera Prognostics announced on Tuesday that it is partnering with health insurer Anthem and its HealthCore subsidiary to conduct a study to determine whether Sera's PreTRM test, along with clinical interventions, can lead to improved health for newborns and mothers.